Home > Products > API > Mepivacaine hydrochloride
Mepivacaine hydrochloride
  • Mepivacaine hydrochlorideMepivacaine hydrochloride

Mepivacaine hydrochloride

Product Name: Mepivacaine hydrochloride
Formula hypothetica: C15H22N2O.ClH
Molecular pondus: 282.81
CAS Subcriptio Number; 1722-62-9

Model:CAS NO:1722-62-9

Mitte Inquisitionem

depictio producti

Mepivacaine hydrochloride

Product nomen:Mepivacaine hydrochloride1722-62-9
CAS No:1722-62-9
Specification: in domo

Nomen Mepivacaine hydrochloride
Synonyma MepivacaineHydrochloride(200mg);RopivacainebaseMepivacaineHCL;(1-methyl-di-piperidine-2-carboxylicacid)-2,6-dimethylanilidehydrochloride;1-methyl-2’,6'-pipecoloxylididehydrochloride;MepivacaineHClUSP; albookidinecarboxamide,N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride;2',6'-Pipecoloxylidide,1-methyl-, monohydrochloride(6CI,8CI); dimethylphenyl) -1-methyl-, monohydrochloride(9CI)
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C15H22N2O.ClH
M. Pondus 282.81
CAS Subcriptio Number 1722-62-9


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Mepivacaine hydrochloride, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept